Journal of Inherited Metabolic Disease

, Volume 9, Issue 4, pp 321–334 | Cite as

Peroxisomes in infantile phytanic acid storage disease: a cytochemical study of skin fibroblasts

  • M. E. Beard
  • A. B. Moser
  • V. Sapirstein
  • E. Holtzman
Article
Received:
Accepted:

Abstract

Cultured skin fibroblasts from six patients demonstrating clinical signs and biochemical characteristics of infantile phytanic acid storage disease (IPSD) were examined by electron microscopy, using cytochemical procedures for the demonstration of peroxisomal catalase activity. In four of the six fibroblast cell lines peroxisomes strongly reactive for catalase were present in numbers similar to those found in normal fibroblasts. Liver biopsy tissue from one of these patients showed no typical hepatic peroxisomes, but did show small, marginally reactive bodies. In two other IPSD fibroblast cell lines peroxisomes with appreciable cytochemical reactivity were rare or absent. It seems, therefore, that infantile phytanic acid storage disease is heterogeneous with respect to the presence of cytochemically recognizable peroxisomes, at least in the cases studied here. Furthermore, peroxisomes may be markedly affected in one cell type — liver — and yet not affected in another — skin fibroblasts — within a single individual.

Keywords

Clinical Sign Catalase Metabolic Disease Liver Biopsy Catalase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arias, J. A., Moser, A. B. and Goldfischer, S. L. Ultrastructural and cytochemical demonstration of peroxisomes in cultured fibroblasts from patients with peroxisomal deficiency disorders.J. Cell. Biol. 100 (1985) 1789–1792Google Scholar
  2. Beard, M. E., Moser, A. B., Sapirstein, V. and Holtzman, E. Is a childhood Refsum's disease a peroxisomal disorder?J. Cell. Biol. 101 (1985b) 67aGoogle Scholar
  3. Beard, M. E., Sapirstein, V., Kolodny, E. H. and Holtzman, E. Peroxisomes in fibroblasts from skin of Refsum's disease patients.J. Histochem. Cytochem. 33 (1985a) 480–484Google Scholar
  4. Bolthauser, E., Spycher, M. A., Steinman, B., Briner, J., Isler, W., Kuster, T., Poulos, A. and Pollar, A. C. Infantile phytanic acid storage disease: A variant of Refsum's disease?Eur. J. Pediatr. 139 (1982) 317Google Scholar
  5. Brown, F. R., McAdams, A. J., Cummins, J. W., Konkol, R., Singh, I., Moser, A. B. and Moser, H. W. Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: Similarities in phenotype and accumulation of very long chain fatty acids.Johns Hopkins Med. J. 151 (1982) 344–361Google Scholar
  6. Budden, S. S., Kennaway, N. G., Buist, N. R. M., Poulos, A. and Weleber, R. G. Dysmorphic syndrome with phytanic acid oxidase deficiency, abnormal very long chain fatty acids and pipecolic acidemia. Studies in four children.J. Pediatr. 108 (1986) 33–39Google Scholar
  7. Burton, B. K., Reeds, S. P. and Remy, W. T. Hyperpipecolic acidemia: Clinical and biochemical observation in two male siblings.J. Pediatr. 99 (1983) 729–734Google Scholar
  8. Farquhar, M. G. and Palade, G. E. Cell junctions in amphibian skin.J. Cell. Biol. 26 (1965) 263–291Google Scholar
  9. Goldfischer, S. Peroxisomes and human metabolic diseases: The cerebrohepatorenal syndrome, cerebrotendinosis xanthomatosis and Schilder's disease (adrenoleukodystrophy).Ann. NY Acad. Sci. 386 (1982) 526–529Google Scholar
  10. Goldfischer, S., Collins, J., Rappin, I., Coltoff-Schiller, B., Chang, C.-H., Nigro, M., Black, V. H., Javitt, N. B., Moser, H. W. and Lazarow, P. B. Peroxisomal defects in neonatal onset and X-linked adrenoleukodystrophies.Science 227 (1985) 67–70Google Scholar
  11. Goldfischer, S. L., Collins, J., Rapin, I., Neumann, P., Neglia, W., Spiro, A. J., Ishii T., Roels, F., Vamecq, J. and Van Hoff, F., Pseudo-Zellweger syndrome: Deficiencies in several peroxisomal oxidative activities.J. Pediatr. 108 (1986) 25–31Google Scholar
  12. Goldfischer, S., Moore, C. L., Johnson, A. B., Spiro, A. J., Valsamis, M. P., Wisniewski, H. K., Ritch, R. H., Norton, W. T., Rapin, I. and Gartner, L. M. Peroxisomal and mitochondrial defects in the cerebrohepatorenal syndrome.Science 182 (1973) 62–64Google Scholar
  13. Goldfischer, S. and Reddy, J. K. Peroxisomes (microbodies) in cell pathology.Int. Rev. Exp. Pathol. 26 (1984) 45–84Google Scholar
  14. Hagey, L. R. and Krisans, S. K.In vitro cholesterol catabolism. A new role for rat liver peroxisomes.J. Cell. Biol. 95 (1982a) 278aGoogle Scholar
  15. Hagey, L. R. and Krisans, S. K. Degradation of cholesterol to propionic acid by rat liver peroxisomes.Biochem. Biophys. Res. Commun. 107 (1982b) 834–841Google Scholar
  16. Hajra, A. K. and Bishop, J. E. Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway.Ann. NY Acad. Sci. 386 (1982) 170–182Google Scholar
  17. Hajra, A. K., Burke, C. C. and Jones, C. L. Peroxisomal localization of acyl coenzyme A: dihydroxyacetone phosphate acyltransferase in rat liver peroxisomes.J. Biol. Chem. 254 (1979) 10896–10900Google Scholar
  18. Herndon, J. H. D., Steinberg, D. and Uhlendorf, B. W. Refsum's disease: defective oxidation of phytanic acid in tissue cultures derived from homozygotes and heterozygotes.N. Engl. J. Med. 281 (1969a) 1034–1038Google Scholar
  19. Herndon, J. H. D., Steinberg, D., Uhlendorf, B. W. and Fales, H. M. Refsum's disease: Characterization of the enzyme defect in cell culture.J. Clin. Invest. 48 (1969b) 1017–1022Google Scholar
  20. Heymans, H. S. A., Oorthuys, J. W. E., Nelck, G., Wanders, R. J. A. and Schutgens, R. B. H. Rhizomelic chondrodysplasia punctata: Another peroxisomal disorder.N. Engl. J. Med. 313 (1985) 187–188Google Scholar
  21. Heymans, H. S. A., Schutgens, R. B. H., Tan, R., van den Bosch, H. and Borst, P. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome).Nature 306 (1983) 69–70Google Scholar
  22. Kase, F., Bjorkhem, I. and Pedersen, J. I. Formation of cholic acid from 3α, 7α, 12α-trihydroxy-5β-cholestanoic acid by rat liver peroxisomes.J. Lipid Res. 24 (1983) 1560–1567Google Scholar
  23. Kindl, H. and Lazarow, P. B. (eds.) Peroxisomes and glyoxysomes.Ann. NY Acad. Sci. vol. 386 (1982).Google Scholar
  24. Krisans, S. K., Thompson, S. L., Pena, L. A. and Kok, E. Bile acid synthesis by rat liver peroxisomes.J. Cell. Biol. 99 (1984) 360aGoogle Scholar
  25. Lazarow, P. B., Black, V., Shio, H., Fujiki, Y., Hajra, A. K., Datta, N. S., Bangaru, B. S. and Dancis, J. Zellweger syndrome: Biochemical and morphological studies on two patients treated with clofibrate.Pediatr. Res. 19 (1985) 1356–1363Google Scholar
  26. Lazarow, P. B. and deDuve, C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes: Enhancement by clofibrate, a hypolipidemic drug.Proc. Natl. Acad. Sci., 73 (1976) 2043–2046Google Scholar
  27. Masters, C. and Crane, D. C. The role of peroxisomes in lipid metabolism.Trends Biochem. Sci. 9 (1984) 314–317Google Scholar
  28. Monnens, L., Bakkeren, J. and Parmentier, G. Disturbances of bile acid metabolism of infants with Zellweger (cerebrohepatorenal) syndrome.Eur. J. Pediatr. 133 (1980) 31–35Google Scholar
  29. Moser, H. W. and Goldfischer, S. The peroxisomal disorders.Hospital Practice (Sept) (1985) 61–70Google Scholar
  30. Novikoff, A. B. and Goldfischer, S. Visualization of peroxisomes (microbodies) and mitochondria with diaminobenzidine.J. Histochem. Cytochem. 17 (1973) 675–680Google Scholar
  31. Ogier, H., Roels, F., Cornelius, A., Poll-The, B.T., Scotto, J. M., Odievre, M. and Saudubray, J. M. Absence of hepatic peroxisomes in a case of infantile Refsum's disease.Scand. J. Clin. Lab. Invest. 45 (1985) 767–768Google Scholar
  32. Partin, J. S. and McAdams, A. J. Absence of hepatic peroxisomes in neonatal adrenoleukodystrophy.Pediatr. Res. 17 (1983) 294a.Google Scholar
  33. Poll-The, B.T., Ogier, H., Saudubray, J. M., Schutgens, R. B. H., Wanders, R. J. A., van den Bosch H. and Schrakamp, G. Impaired plasmalogen metabolism in infantile Refsum's disease.Eur. J. Pediatr. 144 (1985) 514–515Google Scholar
  34. Poll-The, B.T., Saudubray, J. M., Ogier, H., Schutgens, R. B. H., Wanders, R. J. A., Schrakamp, G., van den Bosch, H., Trijbels, J. M. F., Poulos, A., Moser, H. W., van Elder, J. and Eyssen, H. J. Infantile Refsum's disease: biochemical findings suggesting a generalized dysfunction of peroxisomes.J. Inher. Metab. Dis. 9 (1986) 169–174Google Scholar
  35. Poll-The, B.T., Schutgens, R. B. H., Wanders, R. J. A., Roels, F., Poulos, A., Ogier, H. and Saudubray, J. M. Infantile Refsum's disease: Generalized peroxisomal dysfunctions in three revised patients. Joint Unesco-IUB Workshop,Peroxisomes and Their Metabolites in Cellular Functions, Zeist, Holland, 1985bGoogle Scholar
  36. Poulos, A. and Sharp, P. Plasma and skin fibroblasts. C26 fatty acids in infantile Refsum's disease.Neurology 34 (1984) 1606–1609Google Scholar
  37. Poulos, A., Sharp, P., Fellenberg, A. J. and Danks, D. M. Cerebro-hepatorenal (Zellweger) syndrome, adrenoleukodystrophy and Refsum's. Plasma changes and skin fibroblast phytanate oxidase.Hum. Genet. 70 (1985) 172–177Google Scholar
  38. Poulos, A., Sharp, P. and Whiting, M. Infantile Refsum's disease (phytanic acid storage disease): A variant of Zellweger's syndrome?Clin. Genet. 26 (1984) 579–586Google Scholar
  39. Refsum, S., Heredopathic atactica polyneuritiformis. A familial syndrome not hitherto described.Acta Psychiatr. Neurol. Suppl. 38 (1946) 1Google Scholar
  40. Refsum, S., Heredopathic atactica polyneuritiformis. Phytanic acid storage disease (Refsum's disease) In:Handbook of Clinical Neurology 21 (1975) 181–182Google Scholar
  41. Reynolds, S. The use of lead citrate at high pH as an electron opaque stain for electron microscopy.J. Cell. Biol. 17 (1963) 208–212Google Scholar
  42. Schutgens, R. B. H., Heymans, H. S. A., Wanders, R. J. A., van den Bosch, H. and Trager, J. M. Peroxisomal disorders. A newly recognized group of genetic diseases.Eur. J. Pediatr. 612 (1986) 1–11Google Scholar
  43. Schutgens, R. B. H., Romeyn, G. J., Wanders, R. J. A., van den Bosch, H., Schrakamp, G. and Heymans, H. S. A. Deficiency of acyl-CoA dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebrohepatorenal) syndrome.Biochem. Biophys. Res. Commun. 120 (1984) 179–184Google Scholar
  44. Scotto, J. M., Hadchouel, M., Odievre, M., Laudat, M-H, Saudubray, J. M., Dulac, C., Beucler, I. and Beaune, P. Infantile phytanic acid storage disease, three cases, including ultrastructural studies of the liver.J. Inher. Metab. Dis. 5 (1982) 83–90Google Scholar
  45. Singh, I., Moser, A. B., Moser, H. W. and Kishimoto, Y. Adrenoleukodystrophy: Impaired oxidation of very long-chain fatty acids in white blood cells, cultured skin fibroblasts and amniocytes.Pediatr. Res. 18 (1984) 286–290Google Scholar
  46. Singh, I., Moser, H. W., Moser, A. B. and Kishimoto, Y. Adrenoleukodystrophy: Impaired oxidation of long-chain fatty acids in cultured skin fibroblasts and adrenal cortex.Biochem. Biophys. Res. Commun. 102 (1981) 1223–1229Google Scholar
  47. Steinberg, D. Phytanic acid storage disease (Refsum's disease). In Stanbury, J. B., Wyngaarden, J. B. and Fredrickson, D. S. (eds.),The Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1983, pp. 731–747Google Scholar
  48. Steinberg, D., Herndon, J. H. D., Uhlendorf, B. W., Mize, C. E., Avigan, J. and Milne, G. W. A. Refsum's disease: Nature of the enzyme defect.Science 156 (1967) 1740–1742Google Scholar
  49. Stokke, O., Skrede, S., Ek, J. and Bjorkhem, I. Refsum's disease, adrenoleukodystrophy and the Zellweger syndrome.Scand. J. Clin. Lab. Invest. 44 (1984) 463–464Google Scholar
  50. Tsai, S-C., Avigan, J. and Steinberg, D. Studies on the α-oxidation of phytanic acid by rat liver mitochondria.J. Biol. Chem. 144 (1965) 2682–2692Google Scholar

Copyright information

© SSIEM and MTP Press Limited 1986

Authors and Affiliations

  • M. E. Beard
    • 1
  • A. B. Moser
    • 2
  • V. Sapirstein
    • 3
  • E. Holtzman
    • 1
  1. 1.Department of Biological SciencesColumbia UniversityNew YorkUSA
  2. 2.John F. Kennedy Center for Handicapped Children and Department of NeurologyJohns Hopkins UniversityBaltimoreUSA
  3. 3.Eunice K. Shriver Center for Mental Retardation and Department of Biological ChemistryHarvard Medical SchoolWalthamUSA

Personalised recommendations